13F-HR filed by HealthCor Management, L.P.
HealthCor Management, L.P. filed this 13F-HR for the quarter ended 2021-03-31, filed 2021-05-17, with 83 holding rows worth $2,826,431,000.
- Accession
- 0001343781-21-000004
- Filer
- CIK 1343781
- Filed
- 2021-05-17
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2021
A holdings report, 83 entries on the cover page, a total value of $2,826,431,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,826,432,000 with VALUE read as thousands by filing date, 13F file number 028-11790. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 1,725,650 | $158,829,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 666,460 | $143,216,000 | thousands by filing date | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 759,680 | $121,610,000 | thousands by filing date | |
| Danaher Corporation | 235851102 | COM | 535,670 | $120,569,000 | thousands by filing date | |
| HUMANA INC COM | 444859102 | Stock | 251,390 | $105,395,000 | thousands by filing date | |
| Medtronic Plc | G5960L103 | COM | 796,110 | $94,044,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 1,144,287 | $92,996,000 | thousands by filing date | |
| MCKESSON CORP COM | 58155Q103 | Stock | 473,330 | $92,318,000 | thousands by filing date | |
| MARAVAI LIFESCIENCES HLDGS A | 56600D107 | COMMON STOCK | 2,412,712 | $85,989,000 | thousands by filing date | |
| ENCOMPASS HEALTH CORP COM | 29261A100 | Stock | 1,005,316 | $82,335,000 | thousands by filing date | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 1,532,960 | $79,162,000 | thousands by filing date | |
| AbbVie,Inc. | 00287Y109 | COM | 729,420 | $78,938,000 | thousands by filing date | |
| HCA Healthcare Inc | 40412C101 | COM | 414,990 | $78,159,000 | thousands by filing date | |
| IQVIA HLDGS INC COM | 46266C105 | Stock | 401,690 | $77,582,000 | thousands by filing date | |
| CENCORA INC COM | 03073E105 | Stock | 583,290 | $68,869,000 | thousands by filing date | |
| PETCO HEALTH AND WELLNESS CO | 71601V105 | COM | 3,088,000 | $68,430,000 | thousands by filing date | |
| ZOETIS INC CL A | 98978V103 | Stock | 421,860 | $66,435,000 | thousands by filing date | |
| WELLTOWER INC COM | 95040Q104 | REIT | 927,040 | $66,404,000 | thousands by filing date | |
| VENTAS INC COM | 92276F100 | REIT | 1,149,860 | $61,334,000 | thousands by filing date | |
| ENVISTA HOLDINGS CORPORATION | 29415F104 | COM | 1,435,370 | $58,563,000 | thousands by filing date | |
| DEXCOM INC COM | 252131107 | Stock | 142,110 | $51,073,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 4,886,440 | $49,695,000 | thousands by filing date | |
| Boston Scientific Corporation | 101137107 | COM | 1,174,820 | $45,407,000 | thousands by filing date | |
| THE COOPER COMPANIES | 216648402 | COM NEW | 113,167 | $43,466,000 | thousands by filing date | |
| QIAGEN NV | N72482123 | SHS NEW | 838,414 | $40,822,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 187,000 | $40,184,000 | thousands by filing date | call |
| ALIGN TECHNOLOGY INC COM | 016255101 | Stock | 71,460 | $38,698,000 | thousands by filing date | |
| CONMED CORP COM | 207410101 | Stock | 276,940 | $36,166,000 | thousands by filing date | |
| SPY | 78462F103 | SHS | 85,000 | $33,688,000 | thousands by filing date | put |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 219,300 | $33,476,000 | thousands by filing date | |
| Elevance Health, Inc. | 036752103 | COM | 91,760 | $32,937,000 | thousands by filing date | |
| NUANCE COMMUNICATIONS INC | 67020Y100 | COM | 742,030 | $32,382,000 | thousands by filing date | |
| HALOZYME THERAPEUTICS INC COM | 40637H109 | Stock | 745,605 | $31,084,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 1,371,480 | $30,666,000 | thousands by filing date | |
| iShares Russell 2000 ETF | 464287655 | SHS | 135,000 | $29,827,000 | thousands by filing date | put |
| INVESCO QQQ TR | 46090E103 | COM | 90,000 | $28,722,000 | thousands by filing date | put |
| ROYALTY PHARMA PLC | G7709Q104 | SHS CLASS A | 590,790 | $25,770,000 | thousands by filing date | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 207,610 | $23,638,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 900,490 | $23,233,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 80,510 | $22,523,000 | thousands by filing date | |
| VEEVA SYS INC CL A COM | 922475108 | Stock | 85,900 | $22,441,000 | thousands by filing date | |
| SOTERA HEALTH CO | 83601L102 | COM | 805,220 | $20,098,000 | thousands by filing date | |
| LONGVIEW ACQUISITION CORP II | 54319Q204 | UNIT 99/99/9999 | 1,750,000 | $17,570,000 | thousands by filing date | |
| ALLOGENE THERAPEUTICS INC | 019770106 | COM | 494,640 | $17,461,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 227,450 | $17,175,000 | thousands by filing date | |
| HAEMONETICS CORP MASS COM | 405024100 | Stock | 148,480 | $16,483,000 | thousands by filing date | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 618,520 | $15,444,000 | thousands by filing date | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 536,970 | $15,078,000 | thousands by filing date | |
| EHEALTH INC | 28238P109 | COM | 180,000 | $13,091,000 | thousands by filing date | |
| AFFIMED N V | N01045108 | COM | 1,587,944 | $12,561,000 | thousands by filing date | |
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 950,000 | $12,336,000 | thousands by filing date | |
| ARYA SCIENCES ACQU CORP IV | G31659108 | COM | 1,159,360 | $12,141,000 | thousands by filing date | |
| CURIS INC | 231269200 | COM | 977,950 | $11,070,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 462,500 | $10,758,000 | thousands by filing date | |
| RESEARCH ALLIANCE CORP II | 760873109 | CMN | 1,000,000 | $10,250,000 | thousands by filing date | |
| IKENA ONCOLOGY INC | 45175G108 | COM | 341,212 | $9,639,000 | thousands by filing date | |
| ICU MED INC | 44930G107 | COM | 43,960 | $9,031,000 | thousands by filing date | |
| IDEXX LABS INC COM | 45168D104 | Stock | 18,410 | $9,008,000 | thousands by filing date | |
| INNOVAGE HLDG CORP | 45784A104 | COM | 325,000 | $8,382,000 | thousands by filing date | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 736,201 | $8,231,000 | thousands by filing date | |
| MEDICUS SCIENCES ACQUISITION | G5960S116 | UNIT 99/99/9999 | 790,000 | $7,782,000 | thousands by filing date | |
| ORION ACQUISITION CORP | 68626A207 | UNIT 02/19/2026 | 582,920 | $5,829,000 | thousands by filing date | |
| CERNER CORP | 156782104 | COM | 74,420 | $5,349,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 255,000 | $5,253,000 | thousands by filing date | call |
| Instil Bio, Inc. | 45783C101 | Common Stock | 200,000 | $5,016,000 | thousands by filing date | |
| OMEGA ALPHA SPAC | G6749V107 | CL A | 375,000 | $3,713,000 | thousands by filing date | |
| PARDES BIOSCIENCES INC COM | 30318F100 | Stock | 350,000 | $3,486,000 | thousands by filing date | |
| ABG ACQUISITION CORP I | G00496102 | CL A SHS | 350,000 | $3,462,000 | thousands by filing date | |
| EUCRATES BIOMEDICAL ACQU COR | G3141W114 | UNIT 10/23/2027 | 334,180 | $3,362,000 | thousands by filing date | |
| SARISSA CAPITAL ACQUISITN CO | G7823W128 | UNIT 10/23/2027 | 262,150 | $2,839,000 | thousands by filing date | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 34,260 | $2,641,000 | thousands by filing date | |
| FINCH THERAPEUTICS GROUP INC | 31773D101 | COM | 150,000 | $2,423,000 | thousands by filing date | |
| CM LIFE SCIENCES II INC | 125842203 | UNIT 02/25/2028 | 173,563 | $2,222,000 | thousands by filing date | |
| JOUNCE THERAPEUTICS INC | 481116101 | COM | 202,585 | $2,081,000 | thousands by filing date | |
| JIYA ACQUISITION CORP | 47760M102 | CMN | 140,680 | $1,384,000 | thousands by filing date | |
| KINDRED BIOSCIENCES INC COM | 494577109 | Stock | 265,580 | $1,320,000 | thousands by filing date | |
| MERUS N V | N5749R100 | COM | 60,490 | $1,264,000 | thousands by filing date | |
| CONNECT BIOPHARMA HLDGS LTD | 207523101 | SHS | 60,000 | $1,110,000 | thousands by filing date | |
| OMEROS CORP | 682143102 | COM | 50,000 | $890,000 | thousands by filing date | |
| MOONLAKE IMMUNOTHERAPEUTICS | G4444C102 | COM | 60,027 | $613,000 | thousands by filing date | |
| ANIKA THERAPEUTICS INC | 035255108 | COM | 13,540 | $552,000 | thousands by filing date | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 149,170 | $503,000 | thousands by filing date | |
| BCTG ACQUISITION CORP | 05492W103 | COM | 41,032 | $456,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001343781-21-000004 | this filing | 2021-05-17 | acceptance time not in the bulk data set |